These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 38220092)

  • 1. Altering Specificity and Enhancing Stability of the Antimicrobial Peptides Nisin and Rombocin through Dehydrated Amino Acid Residue Engineering.
    Guo L; Stoffels K; Broos J; Kuipers OP
    Peptides; 2024 Apr; 174():171152. PubMed ID: 38220092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rombocin, a Short Stable Natural Nisin Variant, Displays Selective Antimicrobial Activity against
    Guo L; Wambui J; Wang C; Broos J; Stephan R; Kuipers OP
    ACS Synth Biol; 2024 Jan; 13(1):370-383. PubMed ID: 38194633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioengineering of the model lantibiotic nisin.
    Field D; Cotter PD; Ross RP; Hill C
    Bioengineered; 2015; 6(4):187-92. PubMed ID: 25970137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering hybrid lantibiotics yields the highly stable and bacteriocidal peptide cerocin V.
    Guo L; Stoffels K; Broos J; Kuipers OP
    Microbiol Res; 2024 May; 282():127640. PubMed ID: 38350171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The generation of nisin variants with enhanced activity against specific gram-positive pathogens.
    Field D; Connor PM; Cotter PD; Hill C; Ross RP
    Mol Microbiol; 2008 Jul; 69(1):218-30. PubMed ID: 18485077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saturation mutagenesis of lysine 12 leads to the identification of derivatives of nisin A with enhanced antimicrobial activity.
    Molloy EM; Field D; O' Connor PM; Cotter PD; Hill C; Ross RP
    PLoS One; 2013; 8(3):e58530. PubMed ID: 23505531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engineering dehydrated amino acid residues in the antimicrobial peptide nisin.
    Kuipers OP; Rollema HS; Yap WM; Boot HJ; Siezen RJ; de Vos WM
    J Biol Chem; 1992 Dec; 267(34):24340-6. PubMed ID: 1447185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.
    Li Q; Montalban-Lopez M; Kuipers OP
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nisin-A lantibiotic with immunomodulatory properties: A review.
    Małaczewska J; Kaczorek-Łukowska E
    Peptides; 2021 Mar; 137():170479. PubMed ID: 33359393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bioengineering of a Nisin A-producing Lactococcus lactis to create isogenic strains producing the natural variants Nisin F, Q and Z.
    Piper C; Hill C; Cotter PD; Ross RP
    Microb Biotechnol; 2011 May; 4(3):375-82. PubMed ID: 21375711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incorporation of tryptophan analogues into the lantibiotic nisin.
    Zhou L; Shao J; Li Q; van Heel AJ; de Vries MP; Broos J; Kuipers OP
    Amino Acids; 2016 May; 48(5):1309-18. PubMed ID: 26872656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sec-mediated transport of posttranslationally dehydrated peptides in Lactococcus lactis.
    Kuipers A; Wierenga J; Rink R; Kluskens LD; Driessen AJ; Kuipers OP; Moll GN
    Appl Environ Microbiol; 2006 Dec; 72(12):7626-33. PubMed ID: 17041158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of combinations of rationally selected bioengineered nisin derivatives for their ability to inhibit Listeria in broth and model food systems.
    Nyhan L; Field D; Hill C; Callanan M; Begley M
    Food Microbiol; 2021 Oct; 99():103835. PubMed ID: 34119119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lantibiotic Reductase LtnJ Substrate Selectivity Assessed with a Collection of Nisin Derivatives as Substrates.
    Mu D; Montalbán-López M; Deng J; Kuipers OP
    Appl Environ Microbiol; 2015 Jun; 81(11):3679-87. PubMed ID: 25795677
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive mutagenesis of the nisin hinge leads to the rational design of enhanced derivatives.
    Healy B; Field D; O'Connor PM; Hill C; Cotter PD; Ross RP
    PLoS One; 2013; 8(11):e79563. PubMed ID: 24244524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Directionality and coordination of dehydration and ring formation during biosynthesis of the lantibiotic nisin.
    Lubelski J; Khusainov R; Kuipers OP
    J Biol Chem; 2009 Sep; 284(38):25962-72. PubMed ID: 19620240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioengineering of a Lactococcus lactis subsp. lactis strain enhances nisin production and bioactivity.
    Portieles R; Xu H; Chen F; Gao J; Du L; Gao X; Nordelo CB; Yue Q; Zhao L; Gonzalez NP; Bermudez RS; Borrás-Hidalgo O
    PLoS One; 2023; 18(4):e0281175. PubMed ID: 37036850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane-associated proteins encoded by the nisin gene cluster may function as a receptor for the lantibiotic carnocin UI49.
    Stoffels G; Guthmundsdóttir A; Abee T
    Microbiology (Reading); 1994 Jun; 140 ( Pt 6)():1443-50. PubMed ID: 8081505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetics of subtilin and nisin biosyntheses: biosynthesis of lantibiotics.
    Entian KD; de Vos WM
    Antonie Van Leeuwenhoek; 1996 Feb; 69(2):109-17. PubMed ID: 8775971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies with bioengineered Nisin peptides highlight the broad-spectrum potency of Nisin V.
    Field D; Quigley L; O'Connor PM; Rea MC; Daly K; Cotter PD; Hill C; Ross RP
    Microb Biotechnol; 2010 Jul; 3(4):473-86. PubMed ID: 21255345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.